Negotiable / | Min Order Quantity Unit
1 DowGene Genetic Discovery CompanySupplier Activity
tradeKorea provides seller activity to buyers through seller evaluation and measurement according to each item.
" Activity of supplier was updated in the "transaction" section of the last 5 days ago"
Country South Korea
|Product name||[COVID-19] Dow QuickFinder G 2019 nCoV Real time PCR Kit||Certification||CE|
|category||Other Examination & Testing Instrumnet||Ingredients||-|
|Keyword||realtime pcr , coronavirus , covid-19 test , covid-19 real-time kit||Unit Size||-|
|Brand name||Dow QuickFinder™-G 2019-nCoV Real-time PCR Kit||Unit Weigh||-|
|Supply type||-||HS code||382200|
The Dow QuickFinder™-G 2019-nCoV Real-Time PCR Kit is intended to qualitatively measure corona viruses in sputum, pharyngeal and nasopharyngeal swabs using real-time reverse transcription PCR methods. This kit detects three specific target regions of the N gene among the specific target genes of COVID-19.
Optimized for use with ABI 7500 (Fast) or Bio-Rad CFX96 real-time PCR instruments and designed to provide 96 test results per run within 1 hour and 40 minutes. The Dow QuickFinder™-G 2019-nCoV Real-Time PCR Kit is CE-IVD certified, approved for export by the Korean Food and Drug Administration, and is being reviewed for FDA emergency use approval.
Dow QuickFinder™-G 2019-nCoV Real time PCR Kit is in vitro diagnostic reagent to qualitative detection of RdRp, E and N gene (N1, N2) of Novel coronavirus (2019-nCoV) from extracted RNA from Nasopharyngeal swab or Oropharyngeal swab by real-time reverse-transcription PCR method.
In response to skyrocketing demand for testing in Korea, DowGene Co., Ltd. successfully developed, tested, and started manufacturing Dow QuickFinder™-G 2019-nCoV Real-time PCR Test Kit that uses real-time reverse-transcription PCR method for the qualitative detection of RdRp, E and N gene (N1, N2) of Novel coronavirus (2019-nCoV). The product is designed to detect Novel Coronavirus (2019-nCoV) genes quickly and accurately, and rapid and accurate diagnosis can help prevent the spread of the disease by appropriately treating the infected patients. Dow QuickFinder™-G 2019-nCoV Real-Time PCR assay is a real-time RT-PCR assay intended for the qualitative detection of nucleic acid from SARS-CoV-2 in nasopharyngeal or oropharyngeal swab specimens from patients suspected of COVID-19 by their healthcare provider. The instrument has to be installed, calibrated and maintained according to the manufacturer’s instruction and recommendations. Optimized for use with ABI 7500 (Fast) or Bio-Rad CFX96 real-time PCR instruments and designed to provide 96 test results per run within 1 hour 40 minutes. The Dow QuickFinder™-G 2019-nCoV Real-Time PCR Kit is CE-IVD certified, approved for export by the Korean Food and Drug Administration.
|Payment Options||Negotiable||Shipping time||Negotiable|
DowGene Co., Ltd. develops and provides DNA-related services and products,
and our services and products include DNA profile tests for paternity verification, kinship verification, individual identification, remains identification, DNA profile tests for prevention of missing children, food foreign substance detection and kind identification tests, DNA analysis services and DNA storage cards.
DowGene Co., Ltd. is a KOLAS internationally certified testing laboratory and has been Korea's leading DNA testing organization certified by the Ministry of Health and Welfare- affiliated Korean Institute of Genetic Testing Evaluation as a Class A DNA testing institution since the year 2007. All tests performed by DowGene Co., Ltd. are carried out in accordance with a testing quality management system and the best research personnel composed of doctoral researchers who participate in the testing activities to provide the best test quality and accuracy.